Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal Cancer.


Journal

JNCI cancer spectrum
ISSN: 2515-5091
Titre abrégé: JNCI Cancer Spectr
Pays: England
ID NLM: 101721827

Informations de publication

Date de publication:
04 2021
Historique:
received: 03 08 2020
revised: 15 12 2020
accepted: 04 03 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

It was not known whether the polygenic risk scores (PRSs) that predict colorectal cancer could predict colorectal cancer for people with inherited pathogenic variants in DNA mismatch repair genes-people with Lynch syndrome. We tested a PRS comprising 107 established single-nucleotide polymorphisms associated with colorectal cancer in European populations for 826 European-descent carriers of pathogenic variants in DNA mismatch repair genes (293

Identifiants

pubmed: 33928216
doi: 10.1093/jncics/pkab022
pii: pkab022
pmc: PMC8062848
doi:

Substances chimiques

DNA-Binding Proteins 0
EPCAM protein, human 0
Epithelial Cell Adhesion Molecule 0
G-T mismatch-binding protein 0
MLH1 protein, human 0
PMS2 protein, human EC 3.6.1.-
MSH2 protein, human EC 3.6.1.3
Mismatch Repair Endonuclease PMS2 EC 3.6.1.3
MutL Protein Homolog 1 EC 3.6.1.3
MutS Homolog 2 Protein EC 3.6.1.3

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R01 CA114347
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA244588
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA122839
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA167551
Pays : United States
Organisme : NCI NIH HHS
ID : P20 CA252728
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press.

Références

Hum Mutat. 2013 Mar;34(3):490-7
pubmed: 23255516
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Nat Commun. 2019 May 14;10(1):2154
pubmed: 31089142
Nat Genet. 2019 Jan;51(1):76-87
pubmed: 30510241
Int J Epidemiol. 2018 Apr 1;47(2):387-388i
pubmed: 29490034
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):404-412
pubmed: 27799157
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Nat Commun. 2020 Aug 20;11(1):3635
pubmed: 32820175
J Natl Cancer Inst. 2017 Jul 1;109(7):
pubmed: 28376175
Nat Genet. 2014 Feb;46(2):107-115
pubmed: 24362816
Gastroenterology. 2008 Aug;135(2):419-28
pubmed: 18602922

Auteurs

Mark A Jenkins (MA)

Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.
Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia.

Daniel D Buchanan (DD)

Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia.
Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Victoria, Australia.
Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia.

John Lai (J)

Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.
Australian Genome Research Facility, Saint Lucia, Queensland, Australia.

Enes Makalic (E)

Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.

Gillian S Dite (GS)

Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.

Aung K Win (AK)

Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.
Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia.

Mark Clendenning (M)

Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia.
Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Victoria, Australia.

Ingrid M Winship (IM)

Genetic Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.

Richard B Hayes (RB)

Division of Epidemiology, New York University School of Medicine, New York, NY, USA.

Jeroen R Huyghe (JR)

Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Ulrike Peters (U)

Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Steven Gallinger (S)

Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

Loïc Le Marchand (LL)

Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.

Jane C Figueiredo (JC)

Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Rish K Pai (RK)

Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, AZ, USA.

Polly A Newcomb (PA)

Department of Epidemiology, University of Washington, Seattle, WA.
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

James M Church (JM)

Departments of Stem Cell and Regenerative Medicine and Colorectal Surgery, Sanford R Weiss MD Center for Hereditary Colorectal Neoplasia, Digestive Disease and Surgery Institute, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.

Graham Casey (G)

Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.

John L Hopper (JL)

Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH